FDA Commissioner Crawford: For Device Firms, His Reputation Precedes Him
This article was originally published in The Gray Sheet
Executive Summary
Device manufacturers are waiting to see whether FDA Commissioner-nominee Lester Crawford will be responsive to their concerns with the user fee program as he grapples with more high-profile food and drug safety issues